JT Stratford LLC Acquires Shares of 2,805 GE HealthCare Technologies Inc. $GEHC

JT Stratford LLC acquired a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,805 shares of the company’s stock, valued at approximately $226,000.

Several other hedge funds also recently made changes to their positions in GEHC. LGT Financial Advisors LLC raised its holdings in GE HealthCare Technologies by 46.2% during the 4th quarter. LGT Financial Advisors LLC now owns 389 shares of the company’s stock valued at $30,000 after buying an additional 123 shares during the last quarter. Integrated Wealth Concepts LLC increased its position in shares of GE HealthCare Technologies by 0.7% in the fourth quarter. Integrated Wealth Concepts LLC now owns 17,173 shares of the company’s stock valued at $1,343,000 after acquiring an additional 126 shares during the period. Knuff & Co LLC raised its stake in shares of GE HealthCare Technologies by 1.5% during the first quarter. Knuff & Co LLC now owns 10,276 shares of the company’s stock valued at $829,000 after acquiring an additional 150 shares during the last quarter. Graypoint LLC raised its stake in shares of GE HealthCare Technologies by 5.7% during the first quarter. Graypoint LLC now owns 3,028 shares of the company’s stock valued at $244,000 after acquiring an additional 162 shares during the last quarter. Finally, Ferguson Wellman Capital Management Inc. boosted its holdings in shares of GE HealthCare Technologies by 3.2% during the first quarter. Ferguson Wellman Capital Management Inc. now owns 5,336 shares of the company’s stock worth $431,000 after purchasing an additional 166 shares during the period. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Down 0.1%

Shares of NASDAQ:GEHC opened at $73.87 on Thursday. The firm has a market capitalization of $33.73 billion, a P/E ratio of 15.14, a P/E/G ratio of 2.83 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The stock has a 50 day moving average price of $73.94 and a 200-day moving average price of $75.40. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The firm’s revenue for the quarter was up 3.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies announced that its board has approved a stock repurchase program on Wednesday, April 30th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the company to buy up to 3.1% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s board of directors believes its stock is undervalued.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Friday, July 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on GEHC shares. Morgan Stanley reduced their price target on GE HealthCare Technologies from $78.00 to $74.00 and set an “equal weight” rating on the stock in a report on Thursday, July 31st. Evercore ISI reduced their target price on GE HealthCare Technologies from $96.00 to $85.00 and set an “outperform” rating on the stock in a research note on Thursday, May 1st. Citigroup boosted their target price on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a “buy” rating in a research note on Thursday, July 31st. BTIG Research reiterated a “buy” rating on shares of GE HealthCare Technologies in a report on Monday, July 14th. Finally, Wall Street Zen raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, May 31st. Eight investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $88.55.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.